- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of mTOR inhibitors in adult solid organ transplantation
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 15, Issue 3, Pages 303-319
Publisher
Informa Healthcare
Online
2015-12-15
DOI
10.1517/14740338.2016.1132698
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses
- (2015) H. Tedesco- Silva et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Everolimus-based immunosuppressive regimens in lung transplant recipients: Impact on CMV infection
- (2015) Massimo Rittà et al. ANTIVIRAL RESEARCH
- Microangiopatía trombótica asociada a tacrolimus en trasplante pulmonar
- (2015) Juan Pablo Reig Mezquida et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing
- (2015) J. Jia et al. CLINICAL CANCER RESEARCH
- Surgical complications after kidney transplantation: different impacts of immunosuppression, graft function, patient variables, and surgical performance
- (2015) Martina Koch et al. CLINICAL TRANSPLANTATION
- De novomTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation
- (2015) Martina Koch et al. CLINICAL TRANSPLANTATION
- The effect of sirolimus-based immunosuppression vs. conventional prophylaxis therapy on cytomegalovirus infection after liver transplantation
- (2015) Liu Sheng et al. CLINICAL TRANSPLANTATION
- De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus
- (2015) Gerard Cortina et al. PEDIATRIC NEPHROLOGY
- Microangiopatía trombótica asociada a tacrolimus en trasplante pulmonar
- (2015) Juan Pablo Reig Mezquida et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Risk of Metabolic Complications in Kidney Transplantation After Conversion to mTOR Inhibitor: A Systematic Review and Meta-Analysis
- (2014) N. Murakami et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients
- (2014) E. L. Yanik et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Five-Year Outcomes in Kidney Transplant Patients Converted From Cyclosporine to Everolimus: The Randomized ZEUS Study
- (2014) K. Budde et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Everolimus and Early Calcineurin Inhibitor Withdrawal: 3-Year Results From a Randomized Trial in Liver Transplantation
- (2014) M. Sterneck et al. AMERICAN JOURNAL OF TRANSPLANTATION
- De NovoSirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000-2003 Phase II Prospective Randomized Trial
- (2014) S. K. Asrani et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Drug-induced thrombotic microangiopathy: a systematic review of published reports
- (2014) Z. L. Al-Nouri et al. BLOOD
- De novo thrombotic microangiopathy after non-renal solid organ transplantation
- (2014) Annelies Verbiest et al. BLOOD REVIEWS
- Conversion from calcineurin inhibitor-based immunosuppression to mammalian target of rapamycin inhibitors or belatacept in renal transplant recipients
- (2014) Shamkant Mulgaonkar et al. CLINICAL TRANSPLANTATION
- Everolimus-based calcineurin-inhibitor sparing regimens for kidney transplant recipients: a systematic review and meta-analysis
- (2014) Liya Su et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma
- (2014) Robert J. Motzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Making new contacts: the mTOR network in metabolism and signalling crosstalk
- (2014) Mitsugu Shimobayashi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Idiopathic Pulmonary Fibrosis: From Epithelial Injury to Biomarkers - Insights from the Bench Side
- (2014) Keren Borensztajn et al. RESPIRATION
- Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer
- (2014) Yu-Hsuan Chen et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation
- (2014) Lars Mjörnstedt et al. TRANSPLANT INTERNATIONAL
- Acute Rejection, T-Cell–Depleting Antibodies, and Cancer After Transplantation
- (2014) Wai H. Lim et al. TRANSPLANTATION
- Rhabdomyolysis as a Clinical Manifestation of Association With Ciprofibrate, Sirolimus, Cyclosporine, and Pegylated Interferon-α in Liver-Transplanted Patients: A Case Report and Literature Review
- (2014) A.G. dos Santos et al. TRANSPLANTATION PROCEEDINGS
- Everolimus, Cyclosporine, and Thrombotic Microangiopathy: Clinical Role and Preventive Tools in Renal Transplantation
- (2014) F. Nava et al. TRANSPLANTATION PROCEEDINGS
- mTOR Inhibitors and their Role in Modern Concepts of Immunosuppression
- (2014) Björn Nashan WORLD JOURNAL OF SURGERY
- Effect of sirolimus on malignancy and survival after kidney transplantation: systematic review and meta-analysis of individual patient data
- (2014) G. A. Knoll et al. BMJ-British Medical Journal
- Strategies for the management of adverse events associated with mTOR inhibitors
- (2014) Bruce Kaplan et al. Transplantation Reviews
- Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study
- (2013) F. Saliba et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cytomegalovirus in Solid Organ Transplantation
- (2013) R. R. Razonable et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Mammalian target of rapamycin (mTOR) inhibitor-associated non-infectious pneumonitis in patients with renal cell cancer: predictors, management, and outcomes
- (2013) Bradley J. Atkinson et al. BJU INTERNATIONAL
- A Central Role for mTOR in Lipid Homeostasis
- (2013) Dudley W. Lamming et al. Cell Metabolism
- Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors
- (2013) Gianluigi Zaza et al. Clinical & Developmental Immunology
- The utilization of sirolimus and the impact on wound-healing complications in obese kidney transplant recipients
- (2013) Amanda L. Hulbert et al. CLINICAL TRANSPLANTATION
- Wound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trials
- (2013) M. Cooper et al. CLINICAL TRANSPLANTATION
- Evidence for Rapamycin Toxicity in Pancreatic β-Cells and a Review of the Underlying Molecular Mechanisms
- (2013) Adam D. Barlow et al. DIABETES
- The multifaceted role of mTORC1 in the control of lipid metabolism
- (2013) Stéphane J H Ricoult et al. EMBO REPORTS
- The pros and the cons of mTOR inhibitors in kidney transplantation
- (2013) Claudio Ponticelli Expert Review of Clinical Immunology
- Mammalian target of rapamycin inhibitor-associated stomatitis
- (2013) Christine B Boers-Doets et al. Future Oncology
- Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
- (2013) Sampurna Chatterjee et al. JOURNAL OF CLINICAL INVESTIGATION
- Two-Year Randomized Controlled Prospective Trial Converting Treatment of Stable Renal Transplant Recipients With Cutaneous Invasive Squamous Cell Carcinomas to Sirolimus
- (2013) Judith M. Hoogendijk-van den Akker et al. JOURNAL OF CLINICAL ONCOLOGY
- Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation
- (2013) Bijan Ghassemieh et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
- (2013) Camille N. Kotton et al. TRANSPLANTATION
- BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition
- (2013) Johannes Jacobi et al. BMC Nephrology
- Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation
- (2013) V. Ram Peddi et al. Transplantation Reviews
- Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency
- (2012) A. Zuckermann et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Conversion From Cyclosporine to Everolimus at 4.5 Months Posttransplant: 3-Year Results From the Randomized ZEUS Study
- (2012) K. Budde et al. AMERICAN JOURNAL OF TRANSPLANTATION
- The Effect of Everolimus Versus Mycophenolate Upon Proteinuria Following Kidney Transplant and Relationship to Graft Outcomes
- (2012) A. C. Wiseman et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer
- (2012) S. B. Campbell et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Improved Renal Function After Early Conversion From a Calcineurin Inhibitor to Everolimus: a Randomized Trial in Kidney Transplantation
- (2012) L. Mjörnstedt et al. AMERICAN JOURNAL OF TRANSPLANTATION
- CMV Late Phase-Induced mTOR Activation Is Essential for Efficient Virus Replication in Polarized Human Macrophages
- (2012) M. Poglitsch et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation-PROTECT
- (2012) L. Fischer et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Everolimus With Reduced Tacrolimus Improves Renal Function inDe NovoLiver Transplant Recipients: A Randomized Controlled Trial
- (2012) P. De Simone et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
- (2012) Sean Kirby et al. Diagnostic Pathology
- Everolimus-induced Lymphedema in a Renal Transplant Recipient: A Case Report
- (2012) Alparslan Ersoy et al. Experimental and Clinical Transplantation
- Long-term Outcome of Conversion to Sirolimus Monotherapy After Liver Transplant
- (2012) Dirk Uhlmann et al. Experimental and Clinical Transplantation
- Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
- (2012) Sylvie Euvrard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms
- (2012) Daniel C. Brennan et al. REVIEWS IN MEDICAL VIROLOGY
- Everolimus is associated with a reduced incidence of cytomegalovirus infection followingde novocardiac transplantation
- (2012) J. Kobashigawa et al. Transplant Infectious Disease
- Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36 months after transplantation
- (2012) Markus Guba et al. TRANSPLANT INTERNATIONAL
- Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation
- (2012) Robert M Langer et al. TRANSPLANT INTERNATIONAL
- Proteinuria Following Sirolimus Conversion is Associated With Deterioration of Kidney Function in Liver Transplant Recipients
- (2012) Hani M. Wadei et al. TRANSPLANTATION
- Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
- (2012) Björn Nashan et al. TRANSPLANTATION
- Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor–Based Immunosuppression? A Systematic Review and Meta-Analysis
- (2012) Joachim Andrassy et al. TRANSPLANTATION
- Effect of Immunosuppression for Primary Renal Disease on the Risk of Cancer in Subsequent Renal Transplantation
- (2012) Adrian D. Hibberd et al. TRANSPLANTATION
- Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program
- (2012) Alfonsus J.M. van den Eertwegh et al. UROLOGY
- The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients
- (2011) S. M. Flechner et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical Trials
- (2011) D. C. Brennan et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Two Cases of Everolimus-associated Interstitial Pneumonia in Patients with Renal Cell Carcinoma
- (2011) Kentarou Akata et al. INTERNAL MEDICINE
- Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients
- (2011) Eric A. Engels et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Drug-Related Pneumonitis in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus
- (2011) Jose Pablo Maroto et al. JOURNAL OF CLINICAL ONCOLOGY
- Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
- (2011) Klemens Budde et al. LANCET
- AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
- (2011) Joungmok Kim et al. NATURE CELL BIOLOGY
- mTOR inhibition and erythropoiesis: microcytosis or anaemia?
- (2011) F. Diekmann et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sirolimus and Proteinuria in Renal Transplant Patients: Evidence for a Dose-Dependent Effect on Slit Diaphragm-Associated Proteins
- (2011) Giovanni Stallone et al. TRANSPLANTATION
- Everolimus and Long-Term Outcomes in Renal Transplantation
- (2011) Josep M. Campistol et al. TRANSPLANTATION
- Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial
- (2011) Josefina Alberú et al. TRANSPLANTATION
- Summary of the British Transplantation Society Guidelines for the Prevention and Management of CMV Disease After Solid Organ Transplantation
- (2011) Peter A. Andrews et al. TRANSPLANTATION
- Sirolimus Therapy Predisposes to New-Onset Diabetes Mellitus After Renal Transplantation: A Long-Term Analysis of Various Treatment Regimens
- (2011) E. Gyurus et al. TRANSPLANTATION PROCEEDINGS
- Noninfectious Pneumonitis after Everolimus Therapy for Advanced Renal Cell Carcinoma
- (2010) Dorothy A. White et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Phase 3 trial of everolimus for metastatic renal cell carcinoma
- (2010) Robert J. Motzer et al. CANCER
- mTOR inhibitor-associated dermatologic and mucosal problems
- (2010) Josep M. Campistol et al. CLINICAL TRANSPLANTATION
- Thrombotic thrombocytopenic purpura associated with everolimus use in a renal transplant patient
- (2010) Vural Taner Yılmaz et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Sirolimus damages podocytes in rats with protein overload nephropathy
- (2010) Yong Cai et al. JOURNAL OF NEPHROLOGY
- Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial
- (2010) Matthew R. Weir et al. KIDNEY INTERNATIONAL
- Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study
- (2010) H. Ekberg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rhabdomyolysis and acute kidney injury secondary to concomitant use of fluvastatin and rapamycin in a renal transplant recipient
- (2010) N. Basic-Jukic et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway
- (2010) Melinda Oroszlán et al. TRANSPLANT IMMUNOLOGY
- Comparative Analysis of Adverse Events Requiring Suspension of mTOR Inhibitors: Everolimus versus Sirolimus
- (2010) A.I. Sánchez-Fructuoso et al. TRANSPLANTATION PROCEEDINGS
- Cytomegalovirus in Solid Organ Transplant Recipients
- (2009) A. Humar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Interstitial Fibrosis Quantification in Renal Transplant Recipients Randomized to Continue Cyclosporine or Convert to Sirolimus
- (2009) A. Servais et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Immunobiology of Human Cytomegalovirus: from Bench to Bedside
- (2009) T. Crough et al. CLINICAL MICROBIOLOGY REVIEWS
- VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats
- (2009) Laszlo Farkas et al. JOURNAL OF CLINICAL INVESTIGATION
- mTOR complex 2 in adipose tissue negatively controls whole-body growth
- (2009) N. Cybulski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Everolimus With Very Low-Exposure Cyclosporine A in De Novo Kidney Transplantation: A Multicenter, Randomized, Controlled Trial
- (2009) Maurizio Salvadori et al. TRANSPLANTATION
- A Systematic Approach to Minimizing Wound Problems for De Novo Sirolimus-Treated Kidney Transplant Recipients
- (2009) Ho Yee Tiong et al. TRANSPLANTATION
- Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
- (2009) Francesco P. Schena et al. TRANSPLANTATION
- Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
- (2009) A. Cataneo-Dávila et al. TRANSPLANTATION PROCEEDINGS
- Seroepidemiology of Human Polyomaviruses
- (2009) Jaime M. Kean et al. PLoS Pathogens
- Development of Proteinuria After Switch to Sirolimus-Based Immunosuppression in Long-Term Cardiac Transplant Patients
- (2008) A. Z. Aliabadi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Sirolimus Is Associated with New-Onset Diabetes in Kidney Transplant Recipients
- (2008) O. Johnston et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sirolimus interacts with pathways essential for podocyte integrity
- (2008) E. Letavernier et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibidores mTOR y edema unilateral
- (2008) José A. Moro et al. REVISTA ESPANOLA DE CARDIOLOGIA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started